Mechanism of calcitriol regulating parathyroid cells in secondary hyperparathyroidism
A common consequence of chronic renal disease is secondary hyperparathyroidism (SHPT) and is closely related to the mortality and morbidity of uremia patients. Secondary hyperparathyroidism (SHPT) is caused by excessive PTH production and release, as well as parathyroid enlargement. At present, the...
Main Authors: | Zeli Xiang, Ming Wang, Changxiu Miao, Die Jin, Hongyue Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.1020858/full |
Similar Items
-
Laboratory criteria for the persistence of secondary hyperparathyroidism in patients with chronic kidney disease
by: M. Urina, et al.
Published: (2020-11-01) -
Pathomorphological features of parathyroid glands in secondary and tertiary hyperparathyroidism
by: Tkachenko R.P., et al.
Published: (2014-06-01) -
PARATHYROID CANCER OCCURRING IN RELAPSING SECONDARY HYPERPARATHYROIDISM
by: I. V. Kotova, et al.
Published: (2016-12-01) -
Cost-effectiveness analysis of intravenous paricalcitol vs. oral calcitriol in the treatment of hyperparathyroidism secondary to chronic kidney disease
by: Marilia Mastrocolla de Almeida Cardoso, et al.
Published: (2022-08-01) -
ISSUES OF TREATMENT OF SECONDARY HYPERPARATHYROIDISM WITH THE EYES OF AN ANESTHESIOLOGIST. EXPERIENCE OF PERIOPERATIVE ANESTHESIOLOGICAL SUPPORT AND INTENSIVE THERAPY IN PARATHYROID SURGERY
by: A.I. Denysenko, et al.
Published: (2021-06-01)